Forest Laboratories loses Federal Circuit fight against Teva


Forest Laboratories, a subsidiary of Allergan, has failed in its attempt to overturn a district court ruling in its patent battle with Teva.

US Court of Appeals for the Federal Circuit, Forest Laboratories, Teva, patent, Alzheimer’s, Allergan, Namenda XR

More on this story

Actavis to buy Forest for $25 billion